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ABSTRACT OF THESIS

BERYLLIUM NITRATE SUPPORTS FIBROBLAST MIGRATION AS AN
ESSENTIAL COMPONENT OF SKIN AND LIMB REGENERATION IN AXOLOTLS

Tissue regeneration in salamanders is a robust process that is not easily
interrupted or altered. Therefore, inhibiting regeneration provides a means to interrogate
the underlying cellular and molecular mechanisms regulating this complex event. Here
we show that application of a relatively low concentration of beryllium nitrate solution
(100mM) causes a delay in skin regeneration and severely alters normal limb
regeneration. We provide evidence showing a beryllium-induced reduction in dermal
fibroblast migration in vivo and in vitro. We link this phenomenon to delayed
regeneration of the skin and abnormal blastema formation resulting in limb patterning
defects during regeneration. Though our results show a slight reduction in fibroblast
proliferation during the early stages of limb regeneration, we attribute this to an overall
reduction in fibroblast presence at the site of injury. Keratinocytes appeared
unresponsive to beryllium treatment with the rates of re-epithelialization and proliferation
not significantly different between treatment and control groups. Taken together, these
data reinforce a necessary role for fibroblasts during tissue regeneration and show that
beryllium nitrate inhibits normal fibroblast behavior.
KEYWORDS: Beryllium Nitrate, Fibroblast Migration, Mexican Axolotl, Regeneration,
Histology
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CHAPTER 1
INTRODUCTION
Salamanders and newts are unique among tetrapods for their almost limitless
ability to regenerate complex tissues and organs, including an entire limb (Butler and
Ward, 1967; Eguchi et al., 2011; Wallace, 1981). Amazingly, this ability is not restricted
to a single regeneration event as repeated bouts of newt limb amputation continuously
produce new limbs (Spallanzani, 1769). This example underscores the robust nature of
regeneration and hints at the importance of local cells to continually divide and supply
the raw material to faithfully restore a functional limb. Limb regeneration in salamanders
and newts represents an example of epimorphic regeneration whereby cell proliferation
precedes morphogenesis to restore the missing appendage. As cells aggregate at the
injury site they form a blastema, a transient mass of lineage restricted progenitor cells.
Both blastema formation and blastemal cell proliferation are absolutely required for
successful regeneration following limb amputation.
Despite the robust nature of epimorphic regeneration, a few techniques can be
employed to significantly alter and even completely inhibit regeneration of the limb.
There are three classically defined ways to inhibit appendage regeneration: (1) severing
the nerve supply, (2) disrupting positional information and (3) inhibiting cell
proliferation. Examples of nerve dependence can be seen in early regeneration studies on
amphibians. When nerves were severed prior to an amputation of the limb, a blastema
failed to develop and regeneration would not occur until the nerve supply had been
restored (Brockes, 1987; Schotté and Butler, 1941; Singer, 1951; Todd, 1823). While
effective, the effect of denervation is not permanent since neurons regrow into the limb
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stump a short time after the procedure. Re-amputation of a previously denervated limb
will lead to normal regeneration (Salley and Tassava, 1981).
Dermal fibroblasts play a fundamental role during blastema formation and contain
essential patterning information required for limb regeneration (Bryant and Gardiner,
1989; Bryant et al., 2002a; Bryant et al., 2002b; Gardiner et al., 1986; Lheureux, 1975b;
Muneoka et al., 1986). Following an injury and peak inflammatory response, fibroblasts
migrate to the wound site, interact locally, and deposit extracellular matrix (ECM), which
directs cellular proliferation and migration (Calve et al., 2010; Seifert et al., 2012). The
interaction of cells from different circumferential locations is absolutely required for
proper blastema formation (Carlson, 1974; Lheureux, 1975a; Lheureux, 1975b).
Disturbing this pattern by perturbing the normal dorsal-ventral, anterior-posterior, or
proximal-distal axes can cause aberrations in regeneration ranging from supernumerary
limbs to the complete inhibition of regeneration (Bryant, 1976; Slack, 1983).
Proliferation, outgrowth, and differentiation of cells within the blastema formalize their
positional identities, establishing the future pattern of the new limb.
Various chemical and molecular inhibitors have been used to probe the
mechanisms that contribute to regeneration in salamanders. Examples include colchicine,
LE135, Chloramphenicol, and Actinomycin D to name a few (Burnet and Liversage,
1964; Carlson, 1967, 1969; Del Rincon and Scadding, 2002; Thornton, 1943). Retinoic
acid (RA) treatment can proximalize limb stump cells in salamanders and newts,
inducing regeneration of a full limb (e.g., zeugopod, stylopod and autopod) from a distal
plane of amputation (Maden et al., 1985). The absence of RA during limb regeneration
completely inhibits regeneration, as shown by the application of the retinoid antagonist

2

LE135 (Del Rincon and Scadding, 2002). The mechanism for this phenomenon has been
previously elucidated, with RA treatment upregulating the expression of homeobox gene
Meis1, normally expressed proximally in the developed limb (Qin et al., 2002).
Overexpression of Meis1 in distal cells results in proximalization of affected cells in the
absence of RA (Mercader et al., 1999). Exposing axolotl epidermis to Actinomycin D
temporarily inhibits regeneration by delaying the formation of the apical ectodermic cap
(Carlson, 1969). Actinomycin D was later revealed to inhibit RNA transcription by
binding to DNA and hindering RNA polymerase during elongation (Sobell, 1985).
Chloramphenicol is a powerful antibiotic that has been used for over half a century. It is
also known for its potential adverse effects on the patient, most notably its damaging
effect on mitochondria (Yunis, 1989). In fact, treating Notopthalmus viridescens with
chloramphenicol is sufficient to inhibit limb regeneration (Burnet and Liversage, 1964).
Thornton (1943) demonstrated that Colchicine can inhibit limb regeneration in larval
salamanders, and this was later shown to result from Colchicine-induced nerve damage
and inhibited cellular proliferation (Singer et al., 1956). In some cases, these compounds
had toxic side effects on the entire organism, broadly inhibited cellular processes, or
negatively impacted cell proliferation.
In 1949, Charles S. Thornton demonstrated that briefly exposing newly amputated
limbs to the alkaline earth metal beryllium, a compound not utilized by living organisms
in basic cellular functions, completely inhibited limb regeneration in juvenile marbled
salamanders (Ambystoma opacum). Using contralateral limbs as control, the berylliumexposed limbs did not regenerate, whereas the contralateral limb regenerated normally.
Beryllium was the only element of the alkali metal and alkaline earth metal groups shown
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to inhibit regeneration, as Needham (1941) tested multiple elemental compounds of
similar grouping on the periodic table and found that no other metal could inhibit
regeneration at the same exposure time and concentration. Even lithium, an element very
similar to beryllium, had only a minor impact on regeneration and only at much higher
concentrations and exposures. One recent study in Xenopus suggested that beryllium acts
as a potent mediator of inflammation to inhibit larval limb regeneration and another study
suggested that beryllium inhibits cellular function by antagonizing the PIP3 inositol
pathway (Mescher et al., 2013; Tsonis et al., 1991). In light of these studies, and with the
mechanism of beryllium inhibition of regeneration still a mystery, we asked whether
beryllium nitrate might affect the immune response to injury, cell proliferation, death and
migration.
We used the axolotl (Ambystoma mexicanum) to explore the underlying basis of
beryllium inhibition of regeneration. Using a full-thickness excisional skin wound model
(Seifert et al., 2012) and classic limb amputations we show that beryllium exposure dose
not increase immune cell infiltration or increase cell death. Instead, using in vivo and in
vitro techniques we show that beryllium inhibits axolotl fibroblast migration and that this
affects extends to human fibroblasts as well without a concomitant increase in cell death.
Surprisingly, we find that limb regeneration in the axolotl is not completely inhibited, and
that beryllium exposure delays, rather than inhibits, skin regeneration.
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METHODS
Animals
Ambystoma mexicanum (Mexican axolotl) were acquired from the Ambystoma
Genetic Stock Center (AGSC, Lexington, KY) or from our laboratory colony. Animals
were housed individually in an aquatic flow-through system at 17-18˚C in modified
Holtfreter’s Solution and maintained on California blackworms (Lumbriculus variegatus,
J.F. Enterprises, Oakdale, CA). All procedures were conducted in accordance with, and
approved by, the University of Kentucky Institutional Animal Care and Use Committee
(IACUC Protocol: 2013-1174).

Full-thickness Excisional (FTE) Wounding and Limb Amputations
Adult axolotls were anesthetized by full submersion in Benzocaine (SigmaAldrich, St. Louis, MO) 0.01% (aqueous).

Sterile 4mm biopsy punches (Sklar

Instruments, West Chester, PA) were used to create full thickness epithelium (FTE)
wounds through the skin into the dorsal muscle. Four wounds were created per animal on
the dorsal surface posterior to the forelimbs and anterior to the hindlimbs. In order to
harvest wound tissue at specific time-points, animals were anesthetized as above and the
entire wound was harvested by cutting around the wound with iridectomy scissors. For
limb amputations, each limb was amputated through the lower humerus of the forelimbs
perpendicular to the limb with scissors. The protruding bone was trimmed to the stump
to aid wound closure and regeneration.

The regenerating limb was harvested by

amputating just proximal to the original cut site. The left limb and left FTE wound
always served as the experimental group, while the right always served as the control.
Skin wounds were harvested at particular time points post injury based on our previous
5

analysis of skin regeneration in axolotls (Seifert et al., 2012). Limbs were harvested
according to well-established morphological stages of regeneration (Wallace, 1981).

Beryllium Nitrate (BeN) Treatment
A 100mM working stock of beryllium nitrate was prepared by diluting a stock
solution (35% w/v) (Sigma-Aldrich) in distilled water.

Following a single limb

amputation or FTE wound, animals were placed in 100mM BeN for 2 minutes, after
which they were continually rinsed in running tap water for 10 minutes. After rinsing in
water, either the contralateral limb or a second wound corresponding to the mirror
position across the dorsal midline was made and the injuries were allowed to regenerate.
In this way, each animal served as its own control. For in vitro experiments, three
dilutions of BeN were prepared (1mM, 10mM and 100mM) and tested for cytotoxicity.
Cytotoxicity and cell death was assessed using the vital dye Trypan Blue. Based on these
tests 10mM BeN was used in all subsequent cell culture experiments.

Histology and Immunohistochemistry
Harvested tissues were fixed in 10% neutral buffered formalin (NBF) (American
Master Tech Scientific Inc., Lodi, CA) overnight (~16-24hr), washed in phosphate
buffered saline (PBS) (MP Biomedicals LLC, Santa Ana, CA) 3 times, and dehydrated in
70% EtOH. Samples were stored in 70% EtOH at 4˚C until being processed for paraffin
embedding. Limb samples were decalcified in 10% EDTA (pH 7.4) for 3 days at room
temperature with daily changes before processing. All tissue processing was completed
at the University of Kentucky using a rapid microwave histoprocessor (Milestone
Medical Technologies, Kalamazoo, MI).

Tissue was embedded in paraffin (Leica
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Biosystems, Buffalo Grove, IL) and 5 µm sections were placed onto Superfrost Plus
slides (Fisher Scientific).

Tissue sections were processed for routine histology and

stained with Masson’s trichrome (Richard-Allen Scientific, Kalamazoo, MI), Picrosirius
Red (American Master Tech) or Alcian Blue (Sigma-Aldrich). For frozen sections,
samples were fixed for 1 hour in 10% NBF at 4˚C, washed in PBS, equilibrated in 30%
sucrose and OCT freezing medium, and rapidly frozen on dry ice to be stored at -20ºC.
Frozen sections where cut at 12µm.
For general immunohistochemistry preparation, slides were deparaffinized,
rehydrated and antigen retrieval was performed if necessary (see below for each
antibody). Sections were then washed in tris-buffered saline (TBS), blocked for biotin
and streptavidin at 15 minute intervals each (Vector Labs Inc., Burlingame, CA), and
incubated with 1˚ antibody (see below) overnight at 4˚C. Isotyped IgGs matching the
primary antibody were run as negative controls. The following day, slides were washed
in TBS, incubated with biotinylated 2˚ antibody (Vector Labs) for 30 minutes and
subsequently incubated with streptavidin conjugated horseradish peroxidase antibody
(Vector Labs) for 30 minutes.

The antibodies were visualized using DAB (3,3-

diaminobenzidine) (Vector Labs) or incubated with a streptavidin conjugated AlexaFlour 594 (Invitrogen, Carlsbad, CA). Nuclei were counterstained with either 10µg/ml
Hoescht (Invitrogen) for fluorescence or Mayer’s hematoxylin for bright field
visualization. Coverslips were mounted using either ProLong Gold mounting medium
(Invitrogen) for fluorescence or Cytoseal XYL (Thermo-Fisher) for bright field
visualization.
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For BrdU immunohistochemistry, a 3% hydrogen peroxide in methanol block was
applied for 10 minutes prior to rehydration of the deparaffinized sections. Slides were
incubated in a 2M HCl solution at 37ºC for 15 minutes and rinsed 4 times in distilled
water. Reagents A (Avidin DH) and B (Biotinylated Horseradish Peroxidase H) from the
Vectastain ABC kit (Vector Labs) were mixed in a 1:1 ratio of A:B at a concentration of
20µL of each reagent per mL TBS after the application of the biotinylated 2º antibody.
Each slide was treated with this mixture for 30 minutes. After a TBS rinse, reagents from
the DAB substrate kit (Vector Labs) were mixed according to the kit instructions (1 drop
buffer solution, 2 drops DAB stock solution, 1 drop hydrogen peroxide solution, in
2.5mL distilled water). The mixture was applied to each slide individually, observed
through a microscope, and timed for consistency among samples. The reaction was
immediately quenched in distilled water once time elapsed. Slides were counterstained
with Mayer’s hematoxylin for 10 seconds and rinsed in distilled water. All slides were
dehydrated to 100% EtOH, cleared in xylenes, and mounted using Cytoseal XYL.
For EdU immunohistochemistry, sections were deparaffinized and rehydrated in
TBS prior to treatment with EdU labeling reagents. Each slide was incubated in the dark
for 30 minutes with 220µL of an EdU-labeling master mix consisting of 11µL of 2M Tris
at pH 8.5, 4.4µL of 50mM copper(II) sulfate, 0.44µL of Alexafluor azide (Invitrogen) at
0.5mg/mL, 44µL of 0.5M ascorbic acid, and 160.6µL of ddH2O. After a rinse with TBS,
sections were exposed to 1µg/mL Hoescht for 5 mins in the dark, rinsed for 5 mins with
ddH2O, and mounted with ProLong Gold.
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Antibodies
For paraffin sections; L-plastin (gift of P. Martin) 1:2000, Tenascin-c (Millipore,
AB19013), anti-BrdU (Accurate Scientific) 1:500, and Collagen I (Rockland Inc.,
Limerick, PA) 1:500, Ambystoma fibronectin (gift of Thierry Darribere) 1:300. Antigen
retrievals used were; microwave and citrate buffer (pH. 6.0) (L-plastin, Tenascin-c, antiBrdU) for 20 minutes or proteinase K treatment (DAKO) for 2 minutes (collagen type I,
fibronectin).

Negative controls were run using appropriate IgGs at the same

concentration as the 1˚ antibody.

A GFP filter was used to detect autofluorescing

erythrocytes.

Analysis of Cell Death and Proliferation
Cells undergoing apoptosis were detected using a TUNEL assay employing a
GFP tag (Roche Life Sciences, Indianapolis, IN). A cell death index was calculated for
dermal cells expressing GFP divided by the total number of cells (stained with Hoescht)
present in the same counting field.
To detect cells that transitioned through S-phase, 100mg/kg BrdU was IP injected
into axolotls and tissues were harvested after 24 hours. Detection was carried out on
formalin-fixed, paraffin embedded tissue sections.
deparaffinized,

blocked

for

endogenous

After sectioning, sections were

peroxidase

activity

(see

DAB

immunohistochemistry above), rehydrated, antigen retrieved using pH 6.0 sodium citrate
buffer in a rapid microwave histoprocessor (Micron Instruments, Inc. Carlsbad, CA) for
20 minutes, rinsed thoroughly in water and placed in TBS. The standard horseradish
peroxidase visualization protocol was then followed (see DAB immunohistochemistry
above). Further detection of S-phase transition was conducted with 10µg/g EdU, which
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was IP injected into axolotls as described above. Samples were harvested after 24 hours,
formalin fixed, paraffin embedded, and sectioned. The fluorescent visualization protocol
was then followed (see EdU immunohistochemistry above).

GFP Tissue Transplantations
To track dermal fibroblasts in vivo, full-thickness skin comprising dermis and
epidermis was extracted from the dorsal flank of axolotls constitutively expressing GFP
(n=5 individuals per group) in all cell types (see Figure 6A). Identical injuries were made
on wild type (WT) individuals of approximate age and size. Two wounds were made on
WT animals at least 1cm apart, one for treatment with BeN and the other as a control. A
GFP tissue graft was placed into the open wound on WT animals and attached with
Vetbond (3M, Saint Paul, MN). Wounds were allowed to heal and integrate with host
tissue for 2 weeks. After 2 weeks, a second injury was made in the center of the 8mm
GFP transplant using a 4mm biopsy punch. The anterior-most transplant of each animal
was injured first and treated with 100mM BeN for 2 minutes followed by a 10-minute
rinse (see BeN treatment above). A biopsy was taken from the remaining transplant and
this wound served as the control. Each transplant was harvested 14 days later using an
8mm biopsy punch and preserved for cryosectioning. Using this methodology, GFP+
cells in the wound bed were expected to represent fibroblasts because: (1) GFP epidermis
in the original donor tissue was covered and replaced by host WT epidermis, (2)
circulating host blood and immune cells were not GFP+, and (3) the majority of
fibroblast cells are locally derived from a 200-500µm area immediately surrounding the
injury (Mchedlishvili et al., 2007), which constitutively expressed GFP.
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Microscopy and Image Acquisition
Bright-field images were taken on a BX53 light microscope (Olympus, Tokyo,
Japan) using a DP80 CCD camera (Olympus). Whole mount images were taken on an
SZX10 light microscope (Olympus) using a DP73 CCD camera (Olympus). All in vitro
plate images were taken on an IX71 inverted microscope (Olympus) with a DP72 CCD
camera (Olympus).

Tissue from a minimum of three individuals was used for

quantitative data.

Circular Scratch Assays
Two cell types were analyzed in vitro: human adult dermal fibroblasts (hADF)
(gift of Karen Escheveri, acquired from Lonza Group Ltd., Walkersville, MD) and
axolotl fibroblasts (AL1) (gift of Stephanie Roy). Both cell types were expanded in T-25
and T-75 cell culture flasks (Greiner Bio-One, Monroe, NC). AL1 cells were grown in a
media containing 60% L-15 (Leibovitz) Medium without L-glutamine (Sigma-Aldrich),
32% ddH2O, 5% fetal bovine serum (FBS) (GE Healthcare Bio-Sciences, Pittsburgh,
PA), 1% insulin/selenium/transferrin (Life Technologies, Grand Island, NY), 1%
penicillin/streptomycin/amphotericin-b (Sigma-Aldrich), and 1% L-glutamine (Life
Technologies). The hADF cells were grown in a media containing 88% Dulbecco’s
Modified Eagle Medium/F-12 (DMEM) (Life Technologies) 10% FBS (GE Healthcare
Bio-Sciences),

1%

insulin/selenium/transferrin

(Life

Technologies),

1%

penicillin/streptomycin/amphotericin-b (Sigma-Aldrich). Cells were passaged at 70-80%
confluency. Cells were passaged by rinsing with Dulbecco’s PBS solution (DPBS) (Life
Technologies), treating with 0.25% Trypsin-ETDA (Life Technologies) for 3-5 minutes,
and centrifuging for 3 minutes at 3000rpm. Each cell line was split 1:2 or 1:3 into new
11

flasks with fresh media until a large stock of cells was obtained. Additional cells were
slowly frozen in media with 10% DMSO at -80ºC and stored long-term in liquid nitrogen.
Both cell types were grown in 12-well tissue culture treated plates and allowed to reach
~80% confluency prior to any procedure. Half of the wells were treated with 10mM
beryllium nitrate and rinsed 3 times with DPBS. Cells were then scraped off with a cotton
tip applicator in the very center of each well. Images were taken every 12 or 24 hours up
to 96 hours (hADF cells) or 14 days (AL1 cells) following treatment.

Statistics
Basic statistical comparisons between control and experimental groups were
conducted using JMP software (SAS, Cary, NC) to report standard deviation, standard
error of the mean, and to conduct an independent t-test of unequal variance. T-tests were
used to measure differences in cell proliferation in the dermis and epidermis of FTE skin
wounds, differences in fibroblast numbers in the regenerating dermis, and differences
among the percent of AL1 and hADF cells in various stages of the cell cycle.
A two-way ANOVA was used to determine if there were any significant
differences in apoptosis among treated and untreated skin wounds depending on the day
of regeneration, the experimental group, and the interaction between day and group.
Alpha was set at 0.05.
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RESULTS
In order to investigate the effect of beryllium on regenerative ability, we first
sought to replicate C. S. Thornton’s original experiments showing that a short beryllium
exposure completely inhibited limb regeneration (see Methods) (Thornton, 1949, 1950,
1951). Replicating the originally published parameters and substituting juvenile axolotls
(Ambystoma mexicanum) for Ambystoma opacum larvae, we found that limb regeneration
was severely perturbed, but not completely inhibited, in response to beryllium nitrate
(BeN) exposure (Figure 1). Examining control limbs after amputation, we found that a
blastema formed in all animals and progressed through the normal stages of limb
regeneration, ultimately leading to complete regeneration of a normal stylopod, zeugopod
and autopod (Figure 1A-C). In contrast, BeN treated limbs formed a small edema at the
amputation plane that persisted until control limbs had already formed digits (Figure 1D).
Analyzing BeN treated limbs 98 days after injury (D98), we observed very small,
mispatterned limbs that were well-vascularized (Figure 1E).

By D200, some

melanocytes had migrated distally, but limbs remained heteromorphic (Figure 1F). While
the presence of digits and the number was variable across all BeN treated animals,
melanocyte migration was always disrupted (Figure 1E-F). Similar to previous studies,
we found that the degree to which limb regeneration was inhibited was dependent on the
size of the animal and the concentration of beryllium; larger animals required a higher
molar concentration to inhibit limb regeneration (data not shown). We followed some
animals for up to two years after BeN exposure and observed no adverse health affects.
Animals continued to grow and reproduce, which supported previous assertions that
beryllium inhibited regeneration locally, rather than altering whole organism physiology
(Thornton, 1949).
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Seeking to remove the complexity of limb patterning in order to investigate how
beryllium might inhibit regeneration, we turned to a full-thickness skin defect. Our
previous work showed that adult paedomorphic axolotls could completely regenerate a 4
mm full-thickness excisional skin wound in 80 days (Seifert et al., 2012) and we
observed a similar time course during our experiments (Figure 2A, C, E, G).

We

compared BeN treated skin wounds to control wounds and noted several important
effects (Figure 2B, D, F, H). D14 BeN treated wounds showed a similar response to BeN
treated limbs and were notable for a lack of pigment cells migrating into the wound,
persistent presence of edema in the wound bed and increased wound area compared to
controls (Figure 2B). Tracking wounds over time we noted a difference in wound area
between treatment and control groups beginning at D14 (Figure 2A, B). By D21, control
wounds were significantly smaller than BeN treated wounds (9.93 ± 0.91mm2 and 28.77
± 2.82mm2 respectively, t = 6.20, p < 0.002; n=5 per group). In fact, wound area in BeN
treated wounds had more than doubled compared to the original wound area (original
wound = 12.57 mm2 vs. D21 BeN wound area = 28.77 ± 2.82mm2). Whereas the original
wound was difficult to visualize at D64 in control samples, treatment wounds were still
visible at this time point, but became harder to detect by D80 (Figure 2E-H). These
results suggested that BeN exposure inhibited wound contraction following injury.
We next examined the cellular structure of healing wounds and found that
keratinocytes re-epithelialized treatment and control wounds in 24 hours (data not
shown). A thin layer of keratinocytes and Leydig cells covered all wounds within 24
hours of injury and wounding elicited a typical hemostatic response (Figure S1). While
blood cells were present in treatment and control wounds, a large number of erythrocytes
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and plasma persisted in BeN treated wounds until D21 (Figure 2B, D and Figure 3). In
parallel with greater numbers of erythrocytes, ECM deposition was strongly inhibited by
BeN treatment.

While we detected collagen in control wounds beginning at D14,

collagen deposition was not detected in treatment wounds until after D21 (Figure 3). In
D42 control wounds, the regenerating dermis began stratifying into an upper stratum
spongiosum and lower stratum compactum, and new glands were evident regenerating
from the epidermis (Figure 3).

By D80, skin in control wounds had completely

regenerated and resembled unwounded skin (Figure 3). In contrast, D42 BeN treated
wounds developed a dense dermal ECM layer associated with the basement membrane
and no regenerating glands were present (Figure 3). Surprisingly, D80 wounds in BeN
treated skin resembled D42 control wounds, whereby the collagen-rich dermal layer
began subdividing and new glands were evident descending from the epidermis (Figure
3).

At D139, there was little noticeable difference between treatment and control

wounds. Together, these data demonstrated that BeN exposure delayed, but did not
inhibit skin regeneration.
Our observation of reduced collagen deposition following BeN treatment led us to
ask whether other components of the extracellular matrix normally deposited during skin
regeneration were similarly affected (Seifert et al., 2012). Analyzing wound bed tissue at
D14, we found that fibronectin-1 (FN1) and tenascin-C (TNC) were deposited throughout
the regenerating dermis (Figure 4).

We also used Alcian blue to detect

glycosaminoglycan (GAG) production and found it present throughout the wound bed in
control skin (Figure 4). In contrast to control treated wounds, FN1 and TNC were barely
detectable in BeN treated wounds (Figure 4). Similarly, GAGs were not present in the
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wound bed of the treatment group (Figure 4) at D14. Together with our histological
observations, these results indicated that BeN inhibits ECM deposition (directly or
indirectly) and this is associated with a delay in the normal time course of skin
regeneration.
A lack of ECM production in BeN treated wounds suggested three hypotheses:
(H1) a persistent inflammatory response prevented progression to a regenerative response
or (H2) fibroblasts were not present and persistent in the wound or (H3) fibroblasts were
not migrating into the wound bed.

We first sought to test whether BeN treatment

increased cellular inflammation in the wound bed. We assessed leukocyte numbers using
an antibody to L-plastin, a pan-leukocytic marker (Jones et al., 1998; Seifert et al., 2012).
Calculating percent L-plastin+ cells in the wound bed at D7, we found significantly fewer
cells in BeN treated versus control wounds (0.20 ± 0.17% and 3.09 ± 0.49% respectively,
t = -6.10, p < 0.003) (Figure 5). This data showed that BeN did not stimulate increased
inflammatory cell influx into dorsal skin wounds, although erythrocytes and plasma were
found to persist longer in the wound bed in BeN treated wounds.
Dermal fibroblasts are the primary cell type involved in blastema formation
(Gardiner et al., 1986, Muneoka et al., 1986) and are responsible for producing ECM
during regeneration (Asahina et al., 1999; Calve et al., 2010; Gulati et al., 1983; Onda et
al., 1990; Seifert et al., 2012). The relative absence of ECM proteins in the wound bed of
BeN treated wounds suggested fibroblasts might be absent from the wound bed, either
because they failed to migrate into the wounds or because they failed to survive due to
BeN exposure.

We tested multiple commercially available antibodies that label

mammalian fibroblasts (PDGFR-alpha (R+D Systems), vimentin (Sigma-Aldrich), 40E-C
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(Developmental Studies Hybridoma Bank) for their reactivity to axolotl dermal
fibroblasts. Although we used our robust immunohistochemical protocol and tested a
number of variables, including paraffin sections (with various antigen retrievals) and
frozen tissue sections, we were unable to reliably label axolotl fibroblasts (data not
shown). To circumvent this technical limitation, we took advantage of a transgenic
axolotl line in which all cells constitutively express GFP (Sobkow et al., 2006). We
transplanted skin (epidermis and dermis) from axolotls that constitutively express GFP in
all cells into WT hosts (whose cells do not express GFP) in order to track fibroblast
presence and migration into injured tissue (Figure 6A). We counted GFP+ cells at D14
when fibroblasts are normally observed in the wound bed and ECM molecules are readily
detectable (Figure 3 and 4). We found 5.66 ± 1.9% and 0.33 ± 0.11% GFP+ cells in
control and BeN treated wounds respectively (t = -6.44, p < 0.0001, 2-tailed t-test)
(Figure 6B-D). This confirmed that few fibroblasts were present in BeN treated wounds
and suggested that BeN might induce cell death or restrict, either directly or indirectly,
the migratory ability of fibroblasts into the wound. We performed a TUNEL assay on
tissue harvested from control and BeN treated wounds at D1, D3, and D7 to test whether
BeN treatment induced cell death in local fibroblasts and found no significant difference
between groups at any time point (F = 0.2018, p = 0.9583, two-way ANOVA) (Figure
7A-C). Thus, our data showed that BeN treatment primarily affected fibroblast migration
and does not induce cell death in local fibroblasts or in other wound bed cells.
While our transplant experiment demonstrated that fibroblasts failed to move into
the wound bed, we could not rule out that beryllium exposure might affect production of
a chemotactic factor either from the epidermis or other cells within the wound bed. To
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directly test the affect of BeN on cell migration, we cultured axolotl AL1 cells (an
immortalized dermal fibroblast line) and exposed them to BeN. First we tested the
cytotoxicity of three concentrations of BeN based on our 100mM in vivo treatment (i.e.,
1mM, 10mM and 100mM). Using Trypan Blue to detect dead cells, we determined
10mM BeN to be an optimal treatment concentration where minimal cell death occurred
in response to treatment. To assess migratory ability in vitro we created an artificial
wound using a round sterile applicator in the center of each well of a 12-well plate
(Figure 8). Following cells every 24 hours we noted that control (untreated) cells began
migrating into the in vitro wound on D2. By D14 large numbers of untreated cells had
migrated into the wound center (Figure 8). In stark contrast, by D14 we found that few
fibroblasts had migrated into the circular wound (Figure 8). Because we conducted the
assay at ~70-80% confluency, we assessed confluency outside the scratch at D14 and
found that cells were confluent in control and treatment groups (Figure 8). Together,
these data show that axolotl fibroblasts treated with BeN exhibit greatly reduced
migratory behavior compared to control cells without inhibiting cell division.
We next asked if our findings could be expanded to mammalian cells and asked if
BeN treatment reduced the migratory ability of human dermal fibroblasts (hADF cells)
(Figure 9). We performed the same in vitro assay as above and followed hADF cells
every 12 hours (Figure 9). Similar to axolotl AL1 cells, we found that a 10mM treatment
with BeN reduced the migration of cells into scratch wounds. Untreated hADF cells
successfully migrated and completely filled an in vitro wound by 96 hours (Figure 9).
Few BeN treated cells migrated into the scratched area by 96 hours and the area remained
largely uninhabited by cells even 15 days after treatment (Figure 9 and data not shown).
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We also noted a tendency of BeN treated cells to detach from the plastic and remain alive
(Figure 9). Examining cells outside of the scratched areas, we noted that while control
wells reached 100% confluency, cells in treated wells remained at approximately 70%
confluency suggesting limited cell growth (Figure 9).
Although it appeared that axolotl fibroblasts continued growing after BeN
treatment, the failure to reach confluency in hADF cells suggested BeN might affect cell
cycle progression differently in various cell types. Thus, we used flow cytometry to
calculate the relative fraction of cells present in each phase of the cell cycle in order to
gain insight into how BeN might affect cell cycle progression. We first examined AL1
cells. Following control or BeN treatment, we allowed AL1 cells to continue cycling for
48 hours (equal to at least one complete cell cycle) (Maden, 1978; Wallace and Maden,
1976), labeled cells with propidium iodide, and then sorted cells based on their DNA
content (Table 1).

Our analysis indicated that BeN treatment led to a small, but

significant increase in the percentage of cells in S-phase and G2/M-phase (Table 1). The
percentage of cells in G0/G1, however, was not different between treatment and control.
We next analyzed the effect of BeN treatment on proliferation of the regenerating limb in
vivo with EdU during early blastema, mid blastema, and palette stages (Figure S2). We
found a reduction in the proliferative index of the BeN treated group during the blastema
stages (early blastema: control = 20.03 ± 2.59%, treatment = 5.74 ± 1.37%, t = -4.89, p <
0.001; mid blastema: control = 24.49 ± 0.75%, treatment = 14.71 ± 2.86%, t = -3.26, p <
0.01), but a recovery of proliferation at a later stage (palette: control = 24.58 ± 3.29%,
treatment = 26.40 ± 3.63%, t = 0.37, p = 0.71), suggesting either BeN was only
temporarily affecting fibroblast proliferation, or the lack of fibroblasts during the early
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stages of limb regeneration was skewing proliferation counts. Interestingly, when we
analyzed keratinocyte proliferation, we found no difference in the percent of BrdU+ cells
comparing BeN treated epidermis and control epidermis at either 7 days after amputation
(control = 10.56 ± 3.46%, treatment = 7.91 ± 1.77%, t = -0.78, p = 0.447) or 14 days
following amputation (control = 18.15 ± 2.22%, treatment = 24.63 ± 2.29%, t = 2.06, p =
0.048) (Figure S3). Analyzing hADF cells in vitro, we found that BeN had a different
effect on the mammalian cell cycle (Table 1). In contrast to AL1 cells, we found a
significant decrease in the percentage of cells in S-phase and G2/M, whereas the
percentage of cells in G0/G1 increased by 20% (Table 1). Together, this data suggests
that BeN effects cell cycle progression differently in axolotl versus human cells.
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DISCUSSION
Salamanders are known to regenerate their skin and limbs following injury.
Many of the molecular mechanisms that define these processes remain to be discovered.
In this study, we confirmed that beryllium nitrate (BeN) grossly altered regenerating
Ambystoma mexicanum (axolotl) limbs. Furthermore, we demonstrated that a similar
application of BeN to full thickness skin injuries delayed, but did not inhibit skin
regeneration and that BeN affected the ability of fibroblasts to migrate sufficiently into
the wound bed. This in turn resulted in little to no extracellular matrix deposition at the
injury sites. These results support the idea that fibroblasts must migrate into the injury
site and that their presence is necessary for epimorphic regeneration. This is born out of
observations that fibroblasts are necessary to establish a blastema, in the case of limb
regeneration, or deposit and remodel the wound bed ECM in the case of skin
regeneration. Thus, our study provides a cellular mechanism underlying beryllium’s
inhibitory effect on regeneration in salamanders. Interestingly, our results also show that
despite inhibiting local fibroblasts from migrating into skin injuries, additional fibroblasts
from the periphery eventually arrive in the wound bed to regenerate the dermis.
Charles Thornton (1949, 1950, 1951) showed that limb regeneration of
Ambystoma opacum larvae could be completely inhibited with the application of BeN to
a limb stump without any adverse short-term effects to the rest of the organism. Our
experiments treating axolotl larvae with BeN produced stunted, heteromorphic limbs with
few pigment cells and missing digits. There are several explanations for our finding that
limb regeneration was not completely inhibited. First, complete versus partial inhibition
could be attributed to species differences as the original studies used Ambystoma opacum
larvae, although this is unlikely in our opinion given that beryllium inhibits regeneration
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in other Ambystoma species, newts and Xenopus larvae (Mescher et al., 2013; Scheuing
and Singer, 1957; Thornton, 1949, 1950, 1951; Tsonis et al., 1991). Second, the effect of
BeN as a regeneration inhibitor was reported to be size dependent (for a given
concentration), with reduced effects observed on larger organisms (Thornton, 1949). The
axolotl larvae used in the present experiments were larger (7-9 cm) than the A. opacum in
Thornton’s experiments (3-4 cm and 6-7 cm) and thus it is likely that a similar
concentration of BeN (N/7) was insufficient to achieve complete inhibition. It is also
possible that beryllium may affect larval limbs more completely.
Although previous studies showed that beryllium could completely inhibit limb
regeneration in larval salamanders (Needham, 1941; Scheuing and Singer, 1957;
Thornton, 1949; Tsonis et al., 1991), only one study has proposed a possible molecular
mechanism which involves phosphatidylinositol phosphate (PIP) metabolism (Tsonis et
al., 1991). Inositol 1,4,5-trisphosphate (IP3) production was shown to rapidly increase
following limb amputation and then rapidly decrease within 5 minutes (Tsonis et al.,
1991). BeSO4 exposure caused a 22% decrease in PIP metabolism 30 seconds after
amputation, although BeSO4 exposure at later time points had no affect on PIP
metabolism. While this study suggested that BeSO4 exposure inhibits regeneration by
producing an inhibitory effect on cell proliferation because IP3 production has been
linked to cell cycle activation and proliferation (Berridge, 1987), the authors provided no
data on cell proliferation. Scheuing and Singer’s work (1957) using newts also seems to
provide an alternative to the proposed PIP mechanism whereby fully formed blastemas
were directly infused with similar concentrations of BeN and regeneration was inhibited.
Because the treatment occurred many days after injury when IP3 levels are low, it seems
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unlikely that beryllium exerts its inhibitory effect through PIP metabolism. However, it
is possible that beryllium has multiple effects on regeneration, both immediately after
amputation (PIP-IP3 metabolism) and at a later time (BeN infusion of blastemas). We
did find a small decrease in the proliferative index of cells beneath the epidermis at later
time points, although we found no effect on keratinocytes. Given our findings linking
BeN exposure to a migration defect, it is likely that the decrease in cell proliferation is a
consequence of few cells migrating into the wound bed. Interestingly, evidence exists
linking PIP metabolism to cell migration in vitro (Oppelt et al., 2012). Further studies are
required to determine if PIP metabolism is linked to reduced cell migration in salamander
cells.
Beryllium has been explored extensively in the context of chronic berylliosis
disease whereby inhalation of beryllium dust causes an acute chronic inflammation of the
lungs (Newman, 2007). In mammals, this occurs via an acute immune response where
beryllium is identified by the major histocompatibility complex and antigen-presenting
cells that themselves stimulate the proliferation and accumulation of CD4+ helper T cells,
forming granulomatous tissue in the bronchoalveolar lavage of the lungs (Saltini et al.,
1989). Extended beryllium exposure to the skin also leads to an accumulation of CD4+
cells at the point of contact (Fontenot et al., 2002; Saltini et al., 1989). Thus, depending
on varying levels of susceptibility, the adaptive immune response in mammals is
responsible for the symptoms associated with chronic berylliosis disease. Interestingly,
while much of the T-cell receptor complex has remained conserved between amphibians
and mammals (Fellah et al., 1993), functional differences have occurred, specifically in
the V-beta region of the T-cell receptor (Fellah et al., 1994). Generally, the immune
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response of ectothermic organisms is mild relative to the exacting response of the
mammalian immune system and lacks the organization or memory provided by Blymphocytes, which are absent in axolotls (Hsu, 1998). A recent study treated larval
Xenopus laevis with a beryllium solution and showed that beryllium increased the
inflammatory response and this attenuated regenerative ability (Mescher et al., 2013). In
contrast, our results in salamanders exposing limb amputations and skin wounds to BeN
suggested that a sensitized immune system is not present following BeN exposure and
did not account for the lapse in regeneration. While we observed an edema composed of
plasma and erythrocytes consistent with a prolonged hemostatic response, few
inflammatory leukocytes were present at the treatment site. Admittedly, no reagents exist
to detect T-cells in salamanders so we could not assay for increased infiltration of these
cells, and more importantly, T-cell polarization. The depletion macrophages have been
shown in axolotls to inhibit limb regeneration (Godwin et al., 2013). While we cannot
rule out the effect of macrophage reduction on regeneration, we infer that the effect of
this deficit is playing a minor role when viewed in the context of our results and the role
of fibroblasts in regeneration. Taken together, the data suggests that beryllium can act as
an immunostimulatory agent in frogs and mammals, but that immune stimulation does
not underlie the inhibitory effect of beryllium on regeneration in salamanders.
The dermal cell population has been reported to play a large role in limb
regeneration by contributing up to 78% of the cells to the blastema (Muneoka et al.,
1986). We showed that BeN reduces the ability for fibroblasts to migrate in vivo and in
vitro.

Despite poor fibroblast migration during the early stages of regeneration in

response to BeN, some fibroblasts eventually migrated into the injured areas. As a result,
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we observed a delay in skin regeneration, rather than an inhibition.

Where these

additional cells come from is a mystery, although it is possible that there is a fluid
exchange of fibroblasts within the dermis and that given enough time, unaffected
fibroblasts eventually infiltrate the wound site in high enough numbers to produce new
ECM and regenerate the dermis. In the context of limb regeneration, the appearance of a
few digits and carpals suggests that either a very small blastema formed or that a small
accumulation of cells differentiated into the most distal structures. It remains unclear
whether beryllium permanently affects the fibroblasts or if the effect eventually subsides,
however, it is clear that the effect is sufficient to significantly alter limb regeneration and
delay both skin and limb regeneration.
One of the major concern of exposing tissue or cells to a highly reactive element
such as beryllium is the risk of toxicity to basic cellular processes (e.g., DNA synthesis,
cell proliferation, cell death, transcription, etc.).

We addressed these concerns by

quantifying DNA synthesis and by fluorescently labeling dying cells. Beryllium toxicity
has been cited as a caspase-dependent apoptotic pathway (Pulido and Parrish, 2003). We
were able to assess apoptosis through TUNEL labeling and found that BeN exposure did
not increase the number of apoptotic cells in vivo. Some studies suggest that beryllium
has an antagonistic effect on cellular proliferation (Skilleter et al., 1983; Witschi, 1968).
We did observe a small and transient reduction in cell proliferation in wound fibroblasts
and mesenchymal cells beneath the epidermis, however fewer fibroblast cells were
present following treatment. Since we calculated the proliferative index based on cell
density this finding suggests that the observed reduction of proliferation was caused by a
shift in the ratio of fibroblasts to transient, non-proliferative erythrocytes and leukocytes.
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Beryllium affects cell cycle progression, however the magnitude of its effect in vivo was
likely overestimated. Interestingly, proliferation of the epidermis was unaffected by BeN
treatment which implies a targeted, cell-specific interaction rather than a ubiquitous
cytotoxic response. Our in vitro cell cycle analysis showed a small but significant
increase in the number of cells in S-phase and a decrease in the number of cells in G2/Mphase following BeN treatment which suggests a defect at the S/G2 checkpoint. When
we consider our in vivo and in vitro data together it appears as if BeN exposure also
affects cell cycle progression, although as a secondary effect to cell migration since many
cells present at the injury site are proliferating.
We also conducted a cell cycle analysis on an hADF cell line and found that our
results closely mirror those found for rat liver cells exposed to beryllium (Skilleter et al.,
1983). We saw a significantly higher percentage of cells in G1-phase, and a significantly
lower percentage of cells in S-phase and G2/M-phase.

Thus, in mammalian cells,

beryllium exposure results in a more acute, disruptive response to cell cycling compared
to axolotl cells in combination with its effect on fibroblast migration.
Thus, our study shows that beryllium appears to affect endogenous tissue
regeneration in two distinct ways: first, through a disruption of cell migration and second,
through a small, transient interruption of cell cycle progression. It remains unclear if
BeN operates as a mechanical impairment of the cell’s motility systems (extension and
reduction of cytoskeleton or integrin binding) or a sensory impairment of surface
receptors and cell signaling machinery. Our experiments have brought to light an
interesting phenomenon with potential real-world applications in the ongoing effort to
improve clinical efforts to antagonize scarring. Scar formation in mammals results from
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the production of excessive, densely packed collagen fibers following injury or in
response to fibrotic disease. Because BeN exposure appears to limit fibroblast migration
in a cell-type specific manner, an indirect outcome is a reduction in fibrosis. While this
result reduced regenerative ability in a salamander, the in vivo effect in a mammalian
injury may result in decreased scar formation. Future studies could be conducted to
demonstrate the efficacy of low-dose BeN application to mammalian skin injuries,
particularly those prone to high levels of scarring such as frostbite or burn. However,
given the propensity of beryllium to elicit T-cell polarization, the immunostimulatory
effects of beryllium may overwhelm any potential benefits as an anti-fibrotic. In this
respect, beryllium appears to offer a unique tool to tease apart the intricacies of vertebrate
regeneration and scarring.
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TABLES
Table 1. Flow cytometric analysis of the cell cycle revealed that beryllium nitrate
treatment produced an increased percentage of cells in S-phase and G2/M had an
effect on the S/G2 transition in AL1 cells and on the G1/S phase transition in hADF
cells.

AL1 Cell Cycle Analysis
Cell
Population
(n=3)
G0/G1
S
G2/M

Control
(avg %)
44.78
34.31
20.91

Control
SEM (%)
0.91
0.56
0.36

BeN Treated
10mM (avg %)
45.95
39.16
14.89

Treatment
SEM (%)
0.37
0.64
0.31

t-test
(p)
0.2977
0.0047
<0.001

Treatment
CV (%)
0.62
1.35
1.62

t-test
(p)
<0.001
0.042
<0.001

hADF Cell Cycle Analysis
Cell
Population
(n=4)
G0/G1
S
G2/M

Control
(avg %)
52.78
6.19
41.67

Control
SEM (%)
0.37
0.21
0.45

BeN Treated
10mM (avg %)
72.42
2.69
24.89
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FIGURES

Figure 1. BeN treatment delays blastema formation and alters patterning during
axolotl limb regeneration. Amputated limbs treated with BeN were imaged during
regeneration alongside contralateral controls at D24 (A, D), D98 (B, E), and D200 (C, F)
following injury. (A) D24, control limbs showed normal differentiation of the digits,
while BeN treated limbs showed edema (arrows) with no gross signs of blastema
formation (D). (B) Untreated limbs had completely regenerated by 98 days. (E) D98
BeN treated limbs exhibited a delay in regeneration and patterning defects. Moreover,
few melanocytes had migrated into the regenerate (arrows). Compared to control limbs
at D200 (C), BeN treated limbs showed permanent malformations including atypical digit
formation and reduced melanocyte numbers (F). Scale bar = 1mm.
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Figure 2. Beryllium nitrate inhibits wound contraction and delays pigment cell
migration. (A-H) Comparison of full thickness excisional wound healing in control and
BeN treated skin wounds in axolotls. Wounds were followed for 80 days. (A, C) Control
wounds contracted during first 21 days. (B, D) BeN treated wounds expanded from
initial biopsy area and retained large numbers of blood cells through D21. The average
area of treated wounds at D21 was 3x larger than control. (E-F) Pigment cell
(iridophore) migration was reduced in treated wounds. (G-H) D80 control wounds were
indistinguishable from the surrounding unwounded tissue, while treated wounds
maintained a clearly defined wound edge with dermal tissue and muscle still visible
through the epidermis. Scale = 1mm.
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Figure 3. Beryllium nitrate exposure delays skin regeneration. Masson’s trichrome
stained sections comparing control and BeN treated full thickness excisional wounds in
axolotls. Control wounds showed ECM deposition at D14. BeN treated wounds showed
delayed ECM deposition until D42. ECM deposited at D42 was tightly bundled and
localized near the basal lamina. Gland regeneration was apparent in control wounds at
D42 and appeared at D80 in treated wounds. Full thickness skin (dermis and epidermis)
in control wounds had completely regenerated by D80 and resembled unwounded tissue.
Skin regeneration was delayed in treated wounds, with dermis and epidermis mostly
regenerated by D139. Images represent center of the wound bed. Blue = collagen, red =
muscle, purple = cytosol, black = nucleus. Scale = 100µm.
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Figure 4. BeN inhibits early deposition of extracellular matrix (ECM) proteins in
D14 axolotl skin wounds. Panels represent cross sections of full thickness skin showing
epidermis (E), dermis (D) and muscle (M) in control and BeN treated wounds.
Fibronectin-1, Tenascin-C and glycosaminoglycans (GAGs) are visible in the wound bed
of controls, but are absent from BeN treated wounds. GAG presence was visualized with
Alcian blue. Scale = 50µm (Fibronectin), 100µm (Tenascin-C and GAG).

Figure 5. BeN treatment reduces leukocyte infiltration into skin wounds. Axolotl
skin sounds were harvested at D7, and leukocytes were detected with the pan-leukocytic
marker L-plastin. Control wounds contained significantly more L-plastin positive cells
compared to BeN treated wounds (t = -6.10, p < 0.003). Red arrows indicate L-plastin
positive cells in control wounds. Yellow cells are autofluorescing blood cells captured
with the combination of a GFP and RFP filter.
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Figure 6. BeN reduces fibroblast migration into axolotl skin wounds. (A) Schematic
depicts experimental paradigm for tracking GFP-labeled fibroblasts. 8mm skin biopsies
containing epidermis and dermis were harvested from the dorsal flank of ubiquitously
GFP-expressing axolotls (n=5) and transplanted to 8mm wound beds created on WT
animals. Skin transplants were allowed to heal for 14 days after which a 4mm full
thickness wound was made in the center of the transplant. BeN treatment occurred
immediately following injury (see Methods). (B-D) Wound bed tissue was harvested at
D14. (B) Control wounds had significantly more GFP+ cells compared to BeN treated
wounds. (C-D) Red arrows indicate GFP+ cells. Few GFP+ cells were detected in BeN
treated wounds. Erythrocytes that were auto-fluorescent at both red and green
wavelengths and were not counted as GFP+. Scale = 50µm.

Figure 7. BeN treatment does not affect cell death in vivo. TUNEL assay was used to
detect dying cells in axolotl wound bed tissue. (A-C) Percent dying cells were not
different comparing control and BeN treated skin wounds across all time points examined
(two-way ANOVA, F = 0.2018, p = 0.9583). Red arrows indicate TUNEL positive cells.
Yellow cells are auto-fluorescent in both red and green wavelengths and thus were not
counted as GFP+. Scale = 50µm.
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Figure 8. Beryllium nitrate reduces migratory capabilities of axolotl AL1 fibroblast
cells in vitro. (A) Migration of AL1 fibroblasts across the inside edge (dotted line) of a
circular scratch was tracked over the course of 10 days (red dots). The shaded box
indicates an area >90% filled with cells. (B) BeN treatment inhibited migration of AL1
cells and reduced total migration distance. Dotted circle represents the original scratch
area where untreated cells successfully migrated towards the center. Cell density was
~70-80% at treatment and cells in treated and control wells achieved confluency by D14
(red boxed areas). Red arrows indicate detached cells that were present in both treatment
and control groups and did not stain with Trypan Blue (data not shown).
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Figure 9. Beryllium nitrate reduces human dermal fibroblast migration in vitro.
(A) Migration of human dermal fibroblast (hADF) across the inside edge (dotted line) of
a circular scratch was tracked over 48 hours. Few cells treated with BeN migrated into
the in vitro wound whereas control cells completely filled the wound after 96 hours (B).
BeN treatment reduced cell confluence of hADF cells outside of the immediate scratch
area (red box). Red arrows show examples of cells in the treatment that have detached
from the surface and did not stain with Trypan Blue (data not shown).
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APPENDICES

Figure S1. Epidermis migration and wound closure is unaffected by BeN treatment.
Axolotl dorsal flank wounds treated with 100mM BeN were sectioned and stained with
Masson trichrome. Epidermis covered the entire wound surface in both treatment and
control after 24 hours. BeN treated wounds appeared to have portions of the epidermis in
which densely packed erythrocytes interrupted the contiguous layer of Leydig cells.
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Figure S2. Percent EdU+ cells at early blastema, mid blastema, and palette stages of
limb regeneration following treatment with BeN. Axolotl dorsal flank were wounds
treated with 143mM beryllium nitrate, sectioned, and labeled with EdU. Two random
fields of view were imaged and quantified. The treated limb bud had significantly fewer
proliferating cells than the control in the early blastema (control = 20.03 ± 2.59%,
treatment = 5.74 ± 1.37%, t = -4.89, p < 0.001) and the mid blastema (control =
24.49±0.75%, treatment = 14.71 ± 2.86%, t = -3.26, p < 0.01). The proliferative index
was unchanged in the palette stage (control = 24.58 ± 3.29%, treatment = 26.40 ± 3.63%,
t = 0.37, p = 0.71).

Figure S3. Proliferation of Leydig cells and keratinocytes of the epidermis was
unaffected by BeN. (B, C) Proliferating cells, indicated by yellow arrows, had
incorporated BrdU and were counted against the total epidermal cell population. (A)
Proliferative indices were unaffected by the application of beryllium nitrate at both D7
(control = 10.56 ± 3.46%, treatment = 7.91 ± 1.77%, t = -0.78, p = 0.447) and D14
(control = 18.15 ± 2.22%, treatment = 24.63 ± 2.29%, t = 2.06, p = 0.048). Scale =
20µm.
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Figure S4. Beryllium delays ECM deposition and disrupts pattern formation in
regenerating limb buds of the axolotl. (A, C) Extracellular matrix is visible among the
undifferentiated blastema cell populations of the control regenerates. (E) Basal lamina
can be seen beneath the epidermis, followed by signs of early limb patterning of the
untreated palette. (B, D, F) Very little ECM is visible in the mesenchyme of the blastema
or palette of the treatment group. (B) An edema is present in the sub-epidermal space of
the treated early blastema (green arrow). (F) Visible lack of discernable patterning or
basal lamina in the treated equivalent of a palette. (A-F) Treated blastemas have fewer
cells present in the mesenchyme than their untreated counterparts. This disparity
disappears during the later stages of limb regeneration. Scale = 100µm.
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